Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program

Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program

Background Diagnosis of hereditary amyloid transthyretin (hATTR) amyloidosis with cardiomyopathy is frequently delayed, in large part because of symptom overlap with other cardiovascular diseases and limited provider knowledge of this disease. The sponsored and provider referred hATTR Compass Geneti...

Full description

Saved in:
Bibliographic Details
Main Authors: Kunal Bhatt, Diego H. Delgado, Sami Khella, Naresh Bumma, Chafic Karam, Andrew Keller, Andrew M. Rosen, Ana Bozas, Amy Shea, Meghan C. Towne, Linda M. Polfus, Gwendolyn E. Kaeser, Victoria Sanjurjo, Keyur B. Shah
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
amyloidosis
cardiomyopathy
genetic testing
prevalence
transthyretin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.033770
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.033770

Similar Items